A VACCINE AGAINST HEMOPHILUS-INFLUENZAE TYPE-B

被引：13

作者：

DAUM, RS ^{[1
]}

GRANOFF, DM ^{[1
]}

机构：

[1] WASHINGTON UNIV,ST LOUIS CHILDRENS HOSP,SCH MED,EDWARD MALLINCKRODT DEPT PEDIAT,ST LOUIS,MO 63110

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1985年 / 4卷 / 04期

关键词：

D O I：

10.1097/00006454-198507000-00004

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：355 / 357

页数：3

共 26 条

[1] HUMAN SERUM ACTIVITIES AGAINST HEMOPHILUS-INFLUENZAE, TYPE-B [J].

ANDERSON, P ;

SMITH, DH ;

JOHNSTON, RB .

JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (01) :31-&

[2]

ANDERSON P W, 1984, Pediatric Research, V18, p252A, DOI 10.1203/00006450-198404001-00952

[3] SERUM OPSONIC ACTIVITY AFTER IMMUNIZATION OF ADULTS WITH HEMOPHILUS-INFLUENZAE TYPE-B-DIPHTHERIA TOXOID CONJUGATE VACCINE [J].

CATES, KL ;

MARSH, KH ;

GRANOFF, DM .

INFECTION AND IMMUNITY, 1985, 48 (01) :183-189

[4] IMMUNIZATION OF UNITED-STATES CHILDREN WITH HEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE VACCINE - A COST-EFFECTIVENESS MODEL OF STRATEGY ASSESSMENT [J].

COCHI, SL ;

BROOME, CV ;

HIGHTOWER, AW .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (04) :521-529

[5]

COULEHAN JL, 1976, PUBLIC HEALTH REP, V91, P464

[6]

DAVIE JM, 1982, EPIDEMIOLOGY IMMUNOL, P129

[7] POLYSACCHARIDE MENINGOCOCCAL VACCINES - CURRENT STATUS [J].

GOLD, R .

HOSPITAL PRACTICE, 1979, 14 (12) :41-48

[8] RISK-FACTORS FOR PRIMARY INVASIVE HEMOPHILUS-INFLUENZAE DISEASE - INCREASED RISK FROM DAY-CARE ATTENDANCE AND SCHOOL-AGED HOUSEHOLD MEMBERS [J].

ISTRE, GR ;

CONNER, JS ;

BROOME, CV ;

HIGHTOWER, A ;

HOPKINS, RS .

JOURNAL OF PEDIATRICS, 1985, 106 (02) :190-195

[9] CHARACTERIZATION OF HUMAN ANTIBODY TO POLYRIBOPHOSPHATE, CAPSULAR ANTIGEN OF HEMOPHILUS-INFLUENZAE, TYPE-B [J].

JOHNSTON, RB ;

ANDERSON, P ;

ROSEN, FS ;

SMITH, DH .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1973, 1 (02) :234-240

[10]

KAYHTY H, 1984, PEDIATRICS, V74, P857

← 1 2 3 →